Digital Content 
NEWS #PharmaBuzz
22 Jun 2024
// PRESS RELEASE
https://www.takeda.com/newsroom/newsreleases/2024/approval-from-european-commission-for-fruzaqla/
03 Aug 2023
// Zachary Brennan ENDPTS
https://endpts.com/fda-approves-taihos-lonsurf-with-bevacizumab-for-third-line-metastatic-colorectal-cancer/
02 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-lonsurf-trifluridinetipiracil-in-combination-with-bevacizumab-for-adult-patients-with-metastatic-colorectal-cancer-mcrc-301892077.html
13 Jun 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214008
03 May 2023
// BUSINESSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-servier-announce-publication-in-the-new-england-journal-of-medicine-of-pivotal-phase-3-data-for-trifluridinetipiracil-lonsurf-in-combination-with-bevacizumab-in-patients-with-refractory-metastatic-colorectal-301815323.html
18 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-food-and-drug-administration-accepts-for-priority-review-taiho-oncologys-supplemental-new-drug-application-for-the-use-of-trifluridinetipiracil-lonsurf-in-combination-with-bevacizumab-for-refractory-metastatic-colorectal-301799465.html
Share 